Switch to:
More From Other Websites
Panel Recommends FDA Approval of Remicade Knockoff Feb 10 2016
The Generic Drug Battle Feb 10 2016
U.S. Futures Tick Higher as Janet Yellen Worries Over Economy Feb 10 2016
Johnson & Johnson Gets Extrapolated Feb 10 2016
Early movers: TWX, DIS, DB, SPLS, CNX, P & more Feb 10 2016
Johnson & Johnson’s Imbruvica Sees Increased Sales in 4Q15 Feb 10 2016
JNJ’s Pharmaceutical Segment Contributes 45.3% of Revenue in 4Q15 Feb 10 2016
Panel Recommends FDA Approval of Remicade Knockoff Feb 10 2016
FDA panel backs lower-cost version of J&J's top-selling drug Feb 09 2016
Harvard-based weight loss startup combines tech, human coach Feb 09 2016
Pfizer, Reynolds Among Recession Stock Plays — GE, GM For Recovery Feb 09 2016
Tweedy Browne Reopens Global Value Fund II Feb 09 2016
Icahn, Gilead, GE Lead Top Insider Trades Of The Week Feb 09 2016
Local Johnson & Johnson move affects 127 employees Feb 09 2016
What Investors Can Expect from Healthcare Sector Companies Feb 09 2016
Johnson & Johnson to Participate in RBC Capital Markets Global Healthcare Conference Feb 09 2016
What Should A Healthcare Company Do With An Unsolicited Acquisition Offer? Feb 09 2016
FedEx company to take over Johnson & Johnson Memphis operations Feb 08 2016
Valuentum: Bye Bye Energy MLPs, Part II Feb 08 2016




Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK